ID Q19P45_RAT Unreviewed; 182 AA. AC Q19P45; DT 11-JUL-2006, integrated into UniProtKB/TrEMBL. DT 11-JUL-2006, sequence version 1. DT 27-MAR-2024, entry version 97. DE RecName: Full=Cholesterol side-chain cleavage enzyme, mitochondrial {ECO:0000256|ARBA:ARBA00019844, ECO:0000256|RuleBase:RU364077}; DE EC=1.14.15.6 {ECO:0000256|RuleBase:RU364077}; DE AltName: Full=Cholesterol desmolase {ECO:0000256|RuleBase:RU364077}; DE Flags: Fragment; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116 {ECO:0000313|EMBL:ABF70958.1}; RN [1] {ECO:0000313|EMBL:ABF70958.1} RP NUCLEOTIDE SEQUENCE. RC STRAIN=W {ECO:0000313|EMBL:ABF70958.1}; RA Si J.L., Li J., Xu X.Q.; RL Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: A cytochrome P450 monooxygenase that catalyzes the side-chain CC hydroxylation and cleavage of cholesterol to pregnenolone, the CC precursor of most steroid hormones. Catalyzes three sequential CC oxidation reactions of cholesterol, namely the hydroxylation at C22 CC followed with the hydroxylation at C20 to yield 20R,22R- CC hydroxycholesterol that is further cleaved between C20 and C22 to yield CC the C21-steroid pregnenolone and 4-methylpentanal. Mechanistically, CC uses molecular oxygen inserting one oxygen atom into a substrate and CC reducing the second into a water molecule. Two electrons are provided CC by NADPH via a two-protein mitochondrial transfer system comprising CC flavoprotein FDXR (adrenodoxin/ferredoxin reductase) and nonheme iron- CC sulfur protein FDX1 or FDX2 (adrenodoxin/ferredoxin). CC {ECO:0000256|RuleBase:RU364077}. CC -!- CATALYTIC ACTIVITY: CC Reaction=(20R,22R)-20,22-dihydroxycholesterol + 2 H(+) + O2 + 2 reduced CC [adrenodoxin] = 4-methylpentanal + 2 H2O + 2 oxidized [adrenodoxin] + CC pregnenolone; Xref=Rhea:RHEA:34343, Rhea:RHEA-COMP:9998, Rhea:RHEA- CC COMP:9999, ChEBI:CHEBI:1294, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:15379, ChEBI:CHEBI:16581, ChEBI:CHEBI:17998, CC ChEBI:CHEBI:33737, ChEBI:CHEBI:33738; CC Evidence={ECO:0000256|ARBA:ARBA00000397}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:34344; CC Evidence={ECO:0000256|ARBA:ARBA00000397}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(22R)-hydroxycholesterol + 2 H(+) + O2 + 2 reduced CC [adrenodoxin] = (20R,22R)-20,22-dihydroxycholesterol + H2O + 2 CC oxidized [adrenodoxin]; Xref=Rhea:RHEA:34339, Rhea:RHEA-COMP:9998, CC Rhea:RHEA-COMP:9999, ChEBI:CHEBI:1294, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:33737, CC ChEBI:CHEBI:33738, ChEBI:CHEBI:67237; CC Evidence={ECO:0000256|ARBA:ARBA00034008}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:34340; CC Evidence={ECO:0000256|ARBA:ARBA00034008}; CC -!- CATALYTIC ACTIVITY: CC Reaction=21-hydroxyprogesterone + 2 H(+) + O2 + 2 reduced [adrenodoxin] CC = 18-hydroxy-11-deoxycorticosterone + H2O + 2 oxidized [adrenodoxin]; CC Xref=Rhea:RHEA:76151, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:16973, ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, CC ChEBI:CHEBI:195166; Evidence={ECO:0000256|ARBA:ARBA00035593}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76152; CC Evidence={ECO:0000256|ARBA:ARBA00035593}; CC -!- CATALYTIC ACTIVITY: CC Reaction=cholesterol + 2 H(+) + O2 + 2 reduced [adrenodoxin] = (22R)- CC hydroxycholesterol + H2O + 2 oxidized [adrenodoxin]; CC Xref=Rhea:RHEA:34335, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:16113, ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, CC ChEBI:CHEBI:67237; Evidence={ECO:0000256|ARBA:ARBA00034072}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:34336; CC Evidence={ECO:0000256|ARBA:ARBA00034072}; CC -!- CATALYTIC ACTIVITY: CC Reaction=cholesterol + 6 H(+) + 3 O2 + 6 reduced [adrenodoxin] = 4- CC methylpentanal + 4 H2O + 6 oxidized [adrenodoxin] + pregnenolone; CC Xref=Rhea:RHEA:35739, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:16113, ChEBI:CHEBI:16581, ChEBI:CHEBI:17998, CC ChEBI:CHEBI:33737, ChEBI:CHEBI:33738; EC=1.14.15.6; CC Evidence={ECO:0000256|ARBA:ARBA00000117}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35740; CC Evidence={ECO:0000256|ARBA:ARBA00000117}; CC -!- COFACTOR: CC Name=heme; Xref=ChEBI:CHEBI:30413; CC Evidence={ECO:0000256|ARBA:ARBA00001971, CC ECO:0000256|RuleBase:RU364077}; CC -!- PATHWAY: Lipid metabolism; C21-steroid hormone metabolism. CC {ECO:0000256|ARBA:ARBA00005108, ECO:0000256|RuleBase:RU364077}. CC -!- PATHWAY: Steroid metabolism; cholesterol metabolism. CC {ECO:0000256|ARBA:ARBA00004731}. CC -!- SUBUNIT: Interacts with FDX1/adrenodoxin. CC {ECO:0000256|ARBA:ARBA00011573}. CC -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane CC {ECO:0000256|RuleBase:RU364077}; Peripheral membrane protein CC {ECO:0000256|RuleBase:RU364077}. Note=Localizes to the matrix side of CC the mitochondrion inner membrane. {ECO:0000256|RuleBase:RU364077}. CC -!- SIMILARITY: Belongs to the cytochrome P450 family. CC {ECO:0000256|ARBA:ARBA00010617, ECO:0000256|RuleBase:RU364077}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; DQ515795; ABF70958.1; -; mRNA. DR AlphaFoldDB; Q19P45; -. DR UniPathway; UPA00229; -. DR UniPathway; UPA00296; -. DR GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell. DR GO; GO:0008386; F:cholesterol monooxygenase (side-chain-cleaving) activity; IEA:UniProtKB-EC. DR GO; GO:0020037; F:heme binding; IEA:InterPro. DR GO; GO:0005506; F:iron ion binding; IEA:InterPro. DR GO; GO:0008207; P:C21-steroid hormone metabolic process; IEA:UniProtKB-UniPathway. DR GO; GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-UniPathway. DR GO; GO:0006694; P:steroid biosynthetic process; IEA:UniProtKB-KW. DR Gene3D; 1.10.630.10; Cytochrome P450; 1. DR InterPro; IPR001128; Cyt_P450. DR InterPro; IPR002399; Cyt_P450_mitochondrial. DR InterPro; IPR036396; Cyt_P450_sf. DR PANTHER; PTHR24279; -; 1. DR PANTHER; PTHR24279:SF3; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME, MITOCHONDRIAL; 1. DR Pfam; PF00067; p450; 1. DR PRINTS; PR00408; MITP450. DR SUPFAM; SSF48264; Cytochrome P450; 1. PE 2: Evidence at transcript level; KW Cholesterol metabolism {ECO:0000256|RuleBase:RU364077}; KW Heme {ECO:0000256|ARBA:ARBA00022617, ECO:0000256|RuleBase:RU364077}; KW Iron {ECO:0000256|RuleBase:RU364077}; KW Lipid metabolism {ECO:0000256|RuleBase:RU364077}; KW Membrane {ECO:0000256|ARBA:ARBA00023136, ECO:0000256|RuleBase:RU364077}; KW Metal-binding {ECO:0000256|ARBA:ARBA00022723, KW ECO:0000256|RuleBase:RU364077}; KW Mitochondrion {ECO:0000256|RuleBase:RU364077}; KW Monooxygenase {ECO:0000256|RuleBase:RU364077}; KW Oxidoreductase {ECO:0000256|RuleBase:RU364077}; KW Steroid metabolism {ECO:0000256|RuleBase:RU364077}; KW Steroidogenesis {ECO:0000256|RuleBase:RU364077}; KW Sterol metabolism {ECO:0000256|RuleBase:RU364077}; KW Transit peptide {ECO:0000256|ARBA:ARBA00022946, KW ECO:0000256|RuleBase:RU364077}. FT NON_TER 1 FT /evidence="ECO:0000313|EMBL:ABF70958.1" FT NON_TER 182 FT /evidence="ECO:0000313|EMBL:ABF70958.1" SQ SEQUENCE 182 AA; 20867 MW; 830425ADBEFCF915 CRC64; LCLRSVLVKS CQPFLSPVWQ GPGLATGNGA GISSTNSPRS FNEIPSPGDN GWINLYHFLR ENGTHRIHYH HMQNFQKYGP IYREKLGNME SVYILDPKDA ATLFSCEGPN PERYLVPPWV AYHQYYQRPI GVLFKSSDAW RKDRIVLNQE VMAPDSIKNF VPLLEGVAQD FIKVLHRRIK QQ //